Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin collapses visual change detection and drives cortical dynamics toward a state of surprisebioRxiv · 2026-08-25Psychedelics align brain activity with context.Nature · 2026-08-19Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.CNS drugs · 2026-08-13PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-08-13An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanismsBehavioural Pharmacology · 2026-08-01Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.Hearing research · 2026-08-01Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trialCommunications Medicine · 2026-07-30Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from JamaicaFrontiers in Psychiatry · 2026-07-29Identifying factors that contribute to the behavioral effects of psilocybin in preclinical mouse modelsbioRxiv · 2026-07-28Participants' Music Experiences Associated With Psychedelic-Assisted Psychotherapy for Life-Threatening Illness: Interpretivist Research.Journal of music therapy · 2026-07-24No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23Longitudinal neural and psychological changes following psilocybin under compassion imagery primingFrontiers in Human Neuroscience · 2026-07-22Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosisFrontiers in Public Health · 2026-07-20Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18Psilocybin's effect on human brain synaptic plasticity.Translational psychiatry · 2026-07-15Psilocybin-induced behavioral and cellular effectsJournal of Neurogenetics · 2026-07-12First molecular record of Panaeolus subbalteatus (Psathyrellaceae, Agaricales) from Pakistan.Antonie van Leeuwenhoek · 2026-07-09Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in miceMolecular Psychiatry · 2026-07-07CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorderNeuropsychopharmacology · 2026-07-07The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancerBMC Medicine · 2026-07-06Unmixing the psychedelic connectome: Brain network traits of psilocybinNetwork Neuroscience · 2026-07-02Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.Psychopharmacology · 2026-07-01Raman Activity Investigation and Utilization of PsilocybinJournal of Raman Spectroscopy · 2026-07-01Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic reviewJournal of Affective Disorders Reports · 2026-07-01Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholdersPalliative Medicine · 2026-07-01Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-07-01Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.The Australian and New Zealand journal of psychiatry · 2026-07-01Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”PLOS One · 2026-06-30Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortexJournal of Psychopharmacology · 2026-06-28DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in ZebrafishMolecules · 2026-06-18Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-17Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.Proceedings of the National Academy of Sciences of the United States of America · 2026-06-16Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.ACS pharmacology & translational science · 2026-06-12A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's DiseaseClinicalTrials.gov · 2026-06-08Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic ActionCurrent Psychiatry Reports · 2026-06-05Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticityTranslational Psychiatry · 2026-06-052 x 2 Factorial, Double-blind, Randomized Trial of 'Set and Setting': a Translational Study in Healthy VolunteersClinicalTrials.gov · 2026-06-04Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-03Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.The international journal of neuropsychopharmacology · 2026-06-02From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern PsychiatryBJPsych Open · 2026-06-01Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional surveymedRxiv · 2026-06-01Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase developmentJournal of Drug Delivery Science and Technology · 2026-06-01EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CAREValue in Health · 2026-06-01Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin.Molecular psychiatry · 2026-06-01Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.European archives of psychiatry and clinical neuroscience · 2026-06-01Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-29PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-21Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open · 2026-05-15Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-14Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-12Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyJoCN Forum · 2026-05-08Human brain changes after first psilocybin useNature Communications · 2026-05-05The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.The British journal of psychiatry: the journal of mental science · 2026-05-01Effects of psychedelic use on authoritarian attitudes revisited.Journal of psychopharmacology (Oxford, England) · 2026-05-01Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-30Evaluating the evidence for repressed memory recovery in psychedelic contextsPsychopharmacology · 2026-04-28“Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use DisorderAmerican Journal of Neuroradiology · 2026-04-24Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-21Psychedelics: Historical Context, Emerging Science, and Future Clinical FrontiersJournal of Mental Health Disorders · 2026-04-18Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.Current issues in molecular biology · 2026-04-18Effects of a single dose of psilocybin on diet-induced weight loss in obese miceTranslational Psychiatry · 2026-04-14Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-13Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-10Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-09Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionBMC Medical Education · 2026-04-09Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under Psilocybin2026 IEEE 23rd International Symposium on Biomedical Imaging (ISBI) · 2026-04-08Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.MMWR. Morbidity and mortality weekly report · 2026-04-0826-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORTJACC · 2026-04-01Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.Molecular psychiatry · 2026-04-01Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions.Biotechnology and bioengineering · 2026-04-01Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybinJournal of Clinical Epidemiology · 2026-04-01Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.Community mental health journal · 2026-04-01An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse modelProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-04-01Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-31Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-18Psilocybin-facilitated Treatment for Chronic PainClinicalTrials.gov · 2026-03-11Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.CNS & neurological disorders drug targets · 2026-03-11Age moderates the relationship between psychedelics use and mental health in naturalistic settingsResearch Square · 2026-03-10Psilocybin microdosing in the United States: Insights from a nationally representative surveyAddiction · 2026-03-08Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways ForwardAction Research · 2026-03-01Meaning and Psychedelics in Palliative Care: A Narrative Review.Journal of pain and symptom management · 2026-03-01Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence.Exploratory research in clinical and social pharmacy · 2026-03-01Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapyJournal of Affective Disorders · 2026-03-01Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.Biological psychiatry · 2026-02-28Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis.Qualitative health research · 2026-02-17Rebuttal to "Questioning the recovery of dissociated traumatic memories under psilocybin".Journal of eating disorders · 2026-02-17Management of obsessive-compulsive disorder in adults.BMJ (Clinical research ed.) · 2026-02-16Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain.Scientific reports · 2026-02-14Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.Neuroscience and biobehavioral reviews · 2026-02-01Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-20Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb PainClinicalTrials.gov · 2026-01-09Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological AnalysisResearch Explorer (The University of Manchester) · 2026-01-09Behavioral effects of psychedelic and non-psychedelic serotonin 2A receptor agonist drugs in pigsNeuroscience Applied · 2026-01-01Motivation-based subtypes of psilocybin microdosersOpen Collections · 2026-01-01COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDERGenetics and Molecular Research · 2026-01-01Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay MenPalliative Medicine Reports · 2026-01-01Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users' Patterns of Use and Perceived Effects.Journal of psychoactive drugs · 2026-01-01Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.Journal of psychopharmacology (Oxford, England) · 2026-01-01Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use.Journal of psychoactive drugs · 2026-01-01Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi.Journal of AOAC International · 2026-01-01A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally ill.General hospital psychiatry · 2026-01-01An exploration of the relationships between the effects of psilocybin on behavior, 5-HT receptor occupancy, and neuroplastic effects in mice.Journal of psychopharmacology (Oxford, England) · 2026-01-01Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2026-01-01Magic mushrooms and mood: Exploring psilocybin as a depression treatment.JPMA. The Journal of the Pakistan Medical Association · 2026-01-01Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey.Journal of psychoactive drugs · 2026-01-01Effects of Serotonergic Psychedelics on Synaptic Function and NeuroplasticityOPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg · 2025-12-31A qualitative analysis of participant expectations and experiences of psilocybin-assisted psychotherapy for methamphetamine use disorder.Addiction (Abingdon, England) · 2025-12-22Wherefore the magic? The evolutionary role of psilocybin in naturebioRxiv · 2025-12-19Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto RatsPsychedelic Medicine · 2025-12-16Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot StudyJournal of Complementary and Alternative Medical Research · 2025-12-16Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective studyPsyArXiv · 2025-12-10The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female MiceThe Journal of Neuroscience · 2025-12-10Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challengesMycological Progress · 2025-12-08Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case ReportDOAJ (DOAJ: Directory of Open Access Journals) · 2025-12-01Psychedelics for the Treatment of Substance Use DisordersSUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · 2025-12-01Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal NeurogenesisAlzheimer's & dementia: the journal of the Alzheimer's Association · 2025-12-01Between enhancement and risk: A critical review of psychedelic microdosing.Current opinion in psychology · 2025-12-01Corrigendum to "Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder" [Neuropharmacology 279 (2025) 110648].Neuropharmacology · 2025-12-01Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats.Behavioural pharmacology · 2025-12-01Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin.The European journal of neuroscience · 2025-12-01Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.Psychedelic medicine (New Rochelle, N.Y.) · 2025-12-01Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experiencePsychedelics · 2025-11-20Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.Nature communications · 2025-11-20Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.Current gastroenterology reports · 2025-11-19Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-15Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder.Neuropharmacology · 2025-11-15Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genesResearch Square · 2025-11-05Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted TherapyPsychoactives · 2025-11-02Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?Performance Enhancement & Health · 2025-11-01Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.Pilot and feasibility studies · 2025-10-28Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27Structure-Guided Design of Novel 5-HT Partial Agonists as Psychedelic Analogues with Antidepressant Effects.Journal of medicinal chemistry · 2025-10-23Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant EffectsFigshare · 2025-10-15Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSDOpen Science Framework · 2025-10-06Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.Schizophrenia bulletin · 2025-10-06Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric DisordersJournal of Pharma Insights and Research. · 2025-10-05Psilocybin as a Treatment for DepressionUniversity of Debrecen Electronic Archive · 2025-10-02Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02Understanding psilocybin mushrooms and aiding in setting standards for a burgeoning industry in JamaicaPhytochemistry Letters · 2025-10-01Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01Concomitant use of antidepressants and classic psychedelics: A scoping review.Journal of psychopharmacology (Oxford, England) · 2025-10-01Serotonin 5-HT Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.ACS chemical neuroscience · 2025-10-01Dynamic myocardial injury and variable hallucination latency in poisoning: a molecularly confirmed case series from China.Clinical toxicology (Philadelphia, Pa.) · 2025-10-01B-302 Psychedelics and Dissociative Anesthetics: Concentrations in Suspected Impaired Driving Investigations, 2024Clinical Chemistry · 2025-09-30Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.Nature communications · 2025-09-30Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.Addiction (Abingdon, England) · 2025-09-20Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US.Journal of clinical medicine · 2025-09-19Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased AgonismFigshare · 2025-09-13Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy.Healthcare (Basel, Switzerland) · 2025-09-12Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-04PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCHInternational Journal of Innovative Technologies in Social Science · 2025-09-01Psilocybin biosynthesis enhancement through gene source optimization.Metabolic engineering · 2025-09-01An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.Biological psychiatry · 2025-08-15The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of PsilocinACS Pharmacology & Translational Science · 2025-08-08363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIORThe international journal of neuropsychopharmacology · 2025-08-01229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIALThe international journal of neuropsychopharmacology · 2025-08-01476. ACUTE AND CHRONIC PSILOCYBIN IN MOUSE MODELS OF PSYCHIATRIC DISORDERSThe international journal of neuropsychopharmacology · 2025-08-01Letter to the editor: Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024).Molecular psychiatry · 2025-08-01Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.Cureus · 2025-08-01Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics · 2025-07-31Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-15Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome.Chembiochem: a European journal of chemical biology · 2025-07-11The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of PsilocinFigshare · 2025-07-08Exploring Jordanian Physicians' and Medical Students' Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East.Journal of psychoactive drugs · 2025-07-06Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Psychiatry research · 2025-07-01Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.Brain and behavior · 2025-07-01Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.JAMA network open · 2025-07-01A Scoping Review of Research in Naturalistic Studies with Psychedelics.Journal of psychoactive drugs · 2025-06-28Molecular, haemodynamic and functional effects of LSD in the human brainmedRxiv · 2025-06-18The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses.Translational psychiatry · 2025-06-16The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.ACS pharmacology & translational science · 2025-06-13Psilocybin increases emotional empathy in patients with major depression.Molecular psychiatry · 2025-06-01Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.British journal of pain · 2025-06-01Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.Neuroscience and biobehavioral reviews · 2025-06-01Characterization and Identification of an Antimicrobial Compound Psilocybin from Psychedelic Mushroom.Indian journal of microbiology · 2025-06-01Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical PopulationmedRxiv · 2025-05-29Patients' Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment.Journal of psychoactive drugs · 2025-05-29Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa.Journal of eating disorders · 2025-05-26Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23Age and cannabis co-use moderate experience and perceived benefits of psilocybinPsyArXiv · 2025-05-22Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto RatsResearch Square · 2025-05-06Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contextsOpen MIND · 2025-05-04Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische AnwendungNervenheilkunde · 2025-05-01Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case seriesCephalalgia Reports · 2025-05-01Identifying Three Psilocybin Use Patterns by Frequency and Quantity.Journal of studies on alcohol and drugs · 2025-05-01Neurochemical characterization of 5-HTR partial agonists with simultaneous PET-MRI.Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025-05-01ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.Neuroscience and biobehavioral reviews · 2025-05-01Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-05-01From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.Expert review of clinical pharmacology · 2025-05-01